Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03450226
Other study ID # SGB in beating heart surgery
Secondary ID
Status Not yet recruiting
Phase N/A
First received February 19, 2018
Last updated February 27, 2018
Start date March 2018
Est. completion date June 2019

Study information

Verified date February 2018
Source Assiut University
Contact sara abdallah
Phone 01009556520
Email sara92abdallah@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

studies suggest that off-pump coronary artery bypass surgery is associated with improved outcomes when compared to on-pump coronary artery bypass. many studies have shown that off-pump coronary bypass surgery reduces patient morbidity and mortality.

manipulation of the coronary arteries during cardiac surgery can stimulate the adjacent post-ganglionic sympathetic fibers and mimic stellate ganglion stimulation ,stellate ganglion block (SGB) can interrupt this reflex by decreasing the efferent cervical sympathetic outflows.


Description:

when adopting off-pump surgery , the cardiac surgery team must adopt new techniques to handle a beating heart and the variations in hemodynamics that can occur when performing this type of procedure the incidence rate of cardiac arrhythmia occurring during and after surgery is one of the major complication in open heart surgery. in addition , intraoperative hemodynamic disorders, caused by changes in plasma levels of epinephrine and norepinephrine after surgical stimulation , are some of challenges for patients undergoing off-pump coronary artery bypass surgery. hemodynamic disruption leads to myocardial ischemia, resulting in increased incidence of cardiovascular events and mortality.

stellate ganglion is formed by the fusion of inferior cervical and first thoracic sympathetic ganglia and is located behind the subclavian artery and anterior to the first rib. the inferior cervical cardiac nerves arise from the medial aspect of the stellate ganglia and provide the cardio-accelerator nerve fibers to the cardiac plexus. stellate ganglion stimulation augments peak systolic pressure, and the enhanced myocardial contractility is secondary to stimulation by postganglionic nerve fibers which traverse from stellate ganglion down the great vessels and along the coronary arteries into the myocardium.the blockage of inferior cervical cardiac nerves is responsible for the bradycardia seen following SGB. SGB has been shown to prevent and control perioperative hypertension induced by increased sympathetic activity.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date June 2019
Est. primary completion date April 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- patients undergoing elective off-pump coronary artery bypass grafting surgery

- patients with an ejection fraction of more than 50%

- creatinine level of less than 2.0 mg / 100 ml

- no evidence of heart failure

- no significant chronic obstructive lung disease

- age of less than 60 years

Exclusion Criteria:

- emergency surgery

- patients on thrombolytic therapy

- patients with coagulation disorders

- patients requiring heart lung machine

- patients with clinical contraindications to SGB ( including allergy to local anesthetic , carotid vascular disease as defined by ipsilateral prior carotid endarterectomy or carotid stent, superficial infection at the proposed puncture site, contralateral phrenic or laryngeal nerve palsies , and severe chronic obstructive pulmonary disease )

- patients with history of atrial fibrillation

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
stellate ganglion block
After induction of general anesthesia, patients will receive a stellate ganglion block using a standard and well described paratracheal technique, The patient's head will be extended and a 4-5-cm, 22-gauge needle inserted at the medial edge of the sternocleidomastoid muscle just below the level of the cricoid cartilage at the level of the transverse process of C6 or C7. After advancing to the transverse process the needle will be withdrawn 2-3 mm prior to injection. A negative aspiration test will be performed in two planes before a 1-ml test dose is used to exclude unintentional intravascular injection (vertebral or subclavian arteries) or subarachnoid injection into the dural sleeve.4 A total of 10 ml of 0.25% bupivacaine will be injected.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative electrocardiogram changes absence of new onset postoperative cardiac arrhythmia and myocardial infarction after off-pump coronary artery bypass surgery up to 7 days
See also
  Status Clinical Trial Phase
Suspended NCT02741180 - Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias N/A
Not yet recruiting NCT03610529 - CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG N/A
Completed NCT03662802 - Development of a Novel Convolution Neural Network for Arrhythmia Classification
Completed NCT03716076 - Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study Phase 4
Recruiting NCT03053141 - RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Completed NCT03720639 - Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study N/A
Recruiting NCT05968521 - Cardiac Rehabilitation for Young People N/A
Completed NCT04023461 - Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients Phase 4
Completed NCT03319160 - LifeVest Safety and Efficacy in Real Life Settings in France
Active, not recruiting NCT03444259 - Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
Completed NCT03365440 - Esophageal 3D Mapping System for Cardiac Arrhythmias
Completed NCT03195647 - Pilot Study for the Tight K Study Phase 3
Completed NCT03607201 - Acute Coronary Syndrome in Diabetic Patients
Active, not recruiting NCT03614377 - DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)